Evidence map›Paper›PMID 20200935›Full record

ArticleJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research2010

Elevated serum levels of IGF-1 are sufficient to establish normal body size and skeletal properties even in the absence of tissue IGF-1.

Sebastien Elis, Hayden-William Courtland, Yingjie Wu, Clifford J Rosen, Hui Sun, Karl J Jepsen, Robert J Majeska, Shoshana Yakar

Abstract read
In one paragraph

Article in Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed.

  1. Clinical insights into the association between chronic liver disease and osteoporosis.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. A genetic model forOpen biology · 2022
    Article
  6. Article
  7. Postnatal expression ofProceedings. Biological sciences · 2022
    Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Effects of GH/IGF axis on bone and cartilage.Molecular and cellular endocrinology · 2021
    Review
  13. Article
  14. Article
  15. Article
  16. Insulin-like growth factors: actions on the skeleton.Journal of molecular endocrinology · 2018
    Review
  17. Reduced Serum IGF-1 Associated With Hepatic Osteodystrophy Is a Main Determinant of Low Cortical but Not Trabecular Bone Mass.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2018
    Article
  18. Article
  19. Regulation of skeletal growth and mineral acquisition by the GH/IGF-1 axis: Lessons from mouse models.Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society · 2016
    Review
  20. Does the GH/IGF-1 axis contribute to skeletal sexual dimorphism? Evidence from mouse studies.Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sebastien ElisDivision of Endocrinology, Diabetes and Bone Disease, Mount Sinai School of Medicine, New York, NY 10029-6574, USA.
Hayden-William Courtland
Yingjie Wu
Clifford J Rosen
Hui Sun
Karl J Jepsen
Robert J Majeska
Shoshana Yakar

Funding

GENETIC DETERMINATION OF SKELETAL FRAGILITYR01AR044927 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI JEPSEN, KARL J · 2002 to 2014
$4.3M
SERUM IGF-1 DELIVERY SYSTEM AND ITS ROLE IN DETERMINING SKELETAL INTEGRITYR01AR054919 · NIAMS · NEW YORK UNIVERSITY · PI YAKAR, SHOSHANA · 2007 to 2011
$1.8M
THE TEMPORAL AND SPATIAL REGULATION OF BONE ACQUISITION BY SERUM IGF-1R01AR055141 · NIAMS · NEW YORK UNIVERSITY · PI YAKAR, SHOSHANA · 2008 to 2012
$1.8M
Genetic Determination of Skeletal FragilityR56AR044927 · NIAMS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI JEPSEN, KARL J · 2009 to 2009
$500k
GENETIC DETERMINATION OF SKELETAL FRAGILITYR29AR044927 · NIAMS · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI JEPSEN, KARL J · 1998 to 2002
$268k
NIAMS NIH HHS AR054919NIAMS NIH HHS AR055141NIAMS NIH HHS AR44927NIAMS NIH HHS R01 AR044927NIAMS NIH HHS R01 AR054919NIAMS NIH HHS R01 AR055141NIAMS NIH HHS R29 AR044927NIAMS NIH HHS R56 AR044927
6 · The paper itself

Abstract

Use of recombinant insulin-like growth factor 1 (IGF-1) as a treatment for primary IGF-1 deficiency in children has become increasingly common. When untreated, primary IGF-1 deficiency may lead to a range of metabolic disorders, including lipid abnormalities, insulin resistance, and decreased bone density. To date, results of this therapy are considered encouraging; however, our understanding of the role played by IGF-1 during development remains limited. Studies on long-term treatment with recombinant IGF-1 in both children and animals are few. Here, we used two novel transgenic mouse strains to test the long-term effects of elevated circulating IGF-1 on body size and skeletal development. Overexpression of the rat igf1 transgene in livers of mice with otherwise normal IGF-1 expression (HIT mice) resulted in approximately threefold increases in serum IGF-1 levels throughout growth, as well as greater body mass and enhanced skeletal size, architecture, and mechanical properties. When the igf1 transgene was overexpressed in livers of igf1 null mice (KO-HIT), the comparably elevated serum IGF-1 failed to overcome growth and skeletal deficiencies during neonatal and early postnatal growth. However, between 4 and 16 weeks of age, increased serum IGF-1 fully compensated for the absence of locally produced IGF-1 because body weights and lengths of KO-HIT mice became comparable with controls. Furthermore, micro-computed tomography (microCT) analysis revealed that early deficits in skeletal structure of KO-HIT mice were restored to control levels by adulthood. Our data indicate that in the absence of tissue igf1 gene expression, maintaining long-term elevations in serum IGF-1 is sufficient to establish normal body size, body composition, and both skeletal architecture and mechanical function.

Indexed as

Body SizeAnimalsAnimals, NewbornAutocrine CommunicationBiomechanical PhenomenaBone and BonesCell CountGene Expression RegulationInsulin-Like Growth Factor IMiceModels, BiologicalOsteoblastsOsteoclastsParacrine CommunicationPeriosteumSexual MaturationInsulin-Like Growth Factor I

Identifiers

PMID20200935
PMCPMC3153133

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.